Bone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousPeripheral Blood Stem Cell TransplantationBone MarrowBone Marrow CellsGraft vs Host DiseaseTransplantation ConditioningStem Cell TransplantationGraft SurvivalWhole-Body IrradiationLiver TransplantationCyclophosphamideTransplantation ChimeraCombined Modality TherapyTissue DonorsLeukemiaBone and BonesAnemia, AplasticHematopoietic Stem CellsStem CellsBusulfanTreatment OutcomeHematologic NeoplasmsHistocompatibility TestingKidney TransplantationMultiple MyelomaHistocompatibilityHematopoietic Stem Cell MobilizationBone Marrow PurgingRecurrenceTransplantation, IsogeneicAntineoplastic Combined Chemotherapy ProtocolsAntigens, CD34EtoposideGranulocyte Colony-Stimulating FactorRemission InductionImmunosuppressive AgentsHematopoiesisLeukemia, Myeloid, AcuteTime FactorsBone Marrow DiseasesGraft RejectionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMice, Inbred C57BLTransplantation ImmunologyHepatic Veno-Occlusive DiseaseHeart TransplantationRetrospective StudiesPrecursor Cell Lymphoblastic Leukemia-LymphomaRadiation ChimeraLymphoma, Non-HodgkinCord Blood Stem Cell TransplantationImmunosuppressionSurvival AnalysisLymphocyte DepletionLung TransplantationCell TransplantationLeukemia, MyeloidAcute DiseaseHLA AntigensMyelodysplastic SyndromesBone Marrow ExaminationCell DifferentiationT-LymphocytesMelphalanGraft vs Leukemia EffectMesenchymal Stem Cell TransplantationHematologic DiseasesLymphocyte TransfusionSevere Combined ImmunodeficiencySurvival RateLeukocyte TransfusionOrgan TransplantationGraft vs Host ReactionGraft vs Tumor EffectDisease-Free SurvivalFollow-Up StudiesBone RemodelingCyclosporineBone Marrow NeoplasmsColony-Forming Units AssayChimeraCytomegalovirus InfectionsCytarabineCarmustineMyeloablative AgonistsFlow CytometryCells, CulturedActuarial AnalysisChimerismLymphomaNuclear FamilyHodgkin DiseasePrognosisAntilymphocyte SerumPancytopeniaLeukocyte CountIslets of Langerhans Transplantation